EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

A multidimensional pan‐cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma

Shan Wei iD, Kaining Lu, Jing Xing, Wanjun Yu

The FASEB Journal · 2023-04 · 37 (4)

DOI: 10.1096/fj.202201022rrr ↗

Kurz gefasst

Fachartikel in der Zeitschrift The FASEB Journal, online erschienen am 08.03.2023. Verfasst von Shan Wei und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The Affiliated People's Hospital of Ningbo University (Ningbo Yinzhou People's Hospital), Ningb…. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Lung Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

DCAF13 is a substrate recognition protein in the ubiquitin‐proteasome system with oncogenic effects in several malignant tumors. However, it is unclear that the relationship between DCAF13 expression pattern and prognosis across different cancer types. Also unknown is the biological function or effects on the immune microenvironment of DCAF13. In this study, we parsed multiple public databases to explore the potential tumorigenic actions of DCAF13 , including correlations with prognosis, microsatellite instability (MSI), tumor mutational burden (TMB), immune checkpoint genes, immune cell infiltration, and immunotherapy response in pan‐cancer. Moreover, we validated DCAF13 expression in a tissue microarray by immunohistochemistry and investigate its effects in vitro and in vivo. The results showed that DCAF13 was upregulated in 17 cancer types and correlated with poor prognosis in many cancers. Also, the correlation between DCAF13 and TMB was found in 14 cancers as well as MSI in nine. The expression level of DCAF13 was found to be notably correlated with immune cell infiltration, showing a negative correlation with CD4 T cell infiltration and a positive correlation with neutrophil infiltration. The oncogene DCAF13 expression was shown to have a positive correlation with CD274 or ADORA2A and negative correlation with VSIR , TNFRSF4 , or TNFRSF14 across large subsets of human cancers. Finally, we observed that DCAF13 was highly expressed in a tissue microarray of lung cancer. In immunocompromised mouse models, xenograft growth of human lung cancer cells was significantly inhibited by DCAF13 knockdown. Our results highlighted the value of DCAF13 as a promising independent predictor of poor prognosis through numerous biological processes. High DCAF13 expression often predicts suppressive immune microenvironment and immunotherapy resistance in a pan‐cancer context.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungLung NeoplasmsAnimalsMiceHumansOncogenesCarcinogenesisCD4-Positive T-LymphocytesTumor MicroenvironmentRNA-Binding Proteins

Stichwörter der Autor:innen

DCAF13immune checkpointimmunosuppressive microenvironmentpan-cancerprognosis

Substanzen

DCAF13 protein, humanRNA-Binding Proteins

Autor:innen und Institutionen

  • Department of Respiratory and Critical Care Medicine, The Affiliated People's Hospital of Ningbo University (Ningbo Yinzhou People's Hospital), Ningbo, People's Republic of China.
  • Department of Urology, Ningbo First Hospital, Ningbo, People's Republic of China.

ORCID-Profile: Shan Wei

Zitieren

APA

Wei, S., Lu, K., Xing, J., & Yu, W. (2023). A multidimensional pan‐cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. The FASEB Journal, 37(4). https://doi.org/10.1096/fj.202201022rrr

Vancouver

Wei S, Lu K, Xing J, Yu W. A multidimensional pan‐cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma. The FASEB Journal. 2023;37(4). doi:10.1096/fj.202201022rrr

BibTeX
@article{Wei2023,
  author = {Wei, Shan and Lu, Kaining and Xing, Jing and Yu, Wanjun},
  title = {A multidimensional pan‐cancer analysis of DCAF13 and its protumorigenic effect in lung adenocarcinoma},
  journal = {The FASEB Journal},
  year = {2023},
  volume = {37},
  number = {4},
  doi = {10.1096/fj.202201022rrr}
}
Kostenlos starten →